US Stock MarketDetailed Quotes

INO Inovio Pharmaceuticals

Watchlist
  • 10.8300
  • -0.3500-3.13%
Close Jul 24 16:00 ET
  • 10.7300
  • -0.1000-0.92%
Post 17:24 ET
280.61MMarket Cap-1965P/E (TTM)

Inovio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inovio Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 13, 2024

Revenue(YoY)

0.00

-100.00%
EPS(YoY)

-1.31

+30.69%
Analyst Rating

Buy

Jun 30, 2024

Inovio Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 121.670K--
--2024/Q2-- / 121.500K--
May 13, 20242024/Q10.000 / 150.800K--
Mar 6, 20242023/Q4102.650K / 344.120K--
Nov 9, 20232023/Q3388.450K / 262.500K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 121.670K--
--2024/Q2-- / 121.500K--
May 13, 20242024/Q10.000 / 150.800K--
Mar 6, 20242023/Q4102.650K / 344.120K--
Nov 9, 20232023/Q3388.450K / 262.500K--

Unlock Free Earnings Estimates

Inovio Pharmaceuticals Earnings Reports

  • Inovio Pharmaceuticals | 10-Q: Quarterly report

    May 13 16:05 ET

  • Inovio Pharmaceuticals | 10-K: Annual report

    Mar 6 16:06 ET

  • Inovio Pharmaceuticals: Q3 2023 Earnings Report

    Nov 9, 2023 16:00 ET

  • Inovio Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 9, 2023 16:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg